Eyes On FTC After Canada's Drug Sampling Probe Flops
By Bryan Koenig ( January 4, 2019, 5:46 PM EST) -- The U.S. Federal Trade Commission has been actively searching for a case to bring against branded drugmakers the agency suspects of trying to prevent generics companies from developing cheaper rivals to their highly profitable products. But a recent decision by Canadian antitrust authorities indicates the FTC's task won't be so easy....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.